First Tracks: Fresh spinout, fresh buy ratings. First Tracks Biotherapeutics $TRAX climbs roughly 10% with no company news as Canaccord ($50) and Evercore ($65) start coverage bullish. Spun out of AnaptysBio. @petenajarian @jonnajarian follow the tracks because #ITSNOTANOPTION 📙 RebelCon 2026 Oct 19-21 Vegas 👉 https://t.co/3C7PXfRfl5
View on X ↗